Literature DB >> 9411819

[The polymorphism of the angiotensin-converting enzyme gene in patients with hypertension, left ventricular hypertrophy and the development of a myocardial infarct at a young age. Preliminary report].

V S Moiseev, L M Demurov, Zh D Kobalava, D A Chistiakov, S N Tereshchenko, Ia Iu Kondrat'ev, E A Korovina, V V Nosikov.   

Abstract

Insertion/deletion (I/D) polymorphism of angiotensin-I-converting enzyme (ACE) gene was studied by use of the polymerase chain reaction in 168 normal subjects living in Moscow region and in 70 patients: 38 with essential hypertension (EH), 9 of which survived myocardial infarction at young age, 13 with hypertrophic cardiomyopathy (HCMP) and 19 with myocardial infarction (MI). Left ventricular hypertrophy (LVH) was detected in 24 of 38 EH patients. There was a highly significant increase in the frequency of the ID genotype in EH patients compared to the controls (62.4% versus 32.7%, P < 0.01). There was a relevant decrease in the frequency of the DD genotype in EH patients in comparison with the control (20.8% versus 47.6%, P < 0.05). These results strongly suggest that the ACE gene is associated with EH. No significant differences in both allele and genotype frequencies of the ACE gene were revealed in two groups of patients with MI and with HCMP compared to the controls. Thus, no relations between the ACE gene and these disorders were observed. In hypertensives with MI the II genotype was not detected and the frequency of both D allele and DD genotype was sufficiently increased compared to normotensive patients with MI. Thus, the DD genotype in hypertensives may be a risk factor for MI. The frequency of the DD genotype was significantly increased in hypertensive patients with LVH compared to the uncomplicated hypertension (37.5% versus 7.1%, P < 0.05). Therefore, this genotype is associated with LVH in hypertensive subjects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9411819

Source DB:  PubMed          Journal:  Ter Arkh        ISSN: 0040-3660            Impact factor:   0.467


  4 in total

Review 1.  The influence of Angiotensin converting enzyme and angiotensinogen gene polymorphisms on hypertrophic cardiomyopathy.

Authors:  Rong Luo; Xiaoping Li; Yuequn Wang; Yongqing Li; Yun Deng; Yongqi Wan; Zhigang Jiang; Wei Hua; Xiushan Wu
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

Review 2.  Genetic polymorphism of angiotensin-converting enzyme and hypertrophic cardiomyopathy risk: A systematic review and meta-analysis.

Authors:  Ye Yuan; Lin Meng; Yan Zhou; Na Lu
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 3.  Risk Assessment Using the Association Between Renin-Angiotensin Genes Polymorphisms and Coronary Artery Disease.

Authors:  Mohamed Riad; Prakash Adhikari; Sanket Bhattarai; Ashish Gupta; Eiman Ali; Moeez Ali; Jihan A Mostafa
Journal:  Cureus       Date:  2021-03-24

4.  Effect of rs4646994 polymorphism of angiotensin-converting enzyme on the risk of nonischemic cardiomyopathy.

Authors:  Jinsheng Shen; Xuesong Qian; Xiaofei Mei; Jialu Yao; Hezi Jiang; Kexin Li; Tan Chen; Yufeng Jiang; Yafeng Zhou
Journal:  Biosci Rep       Date:  2021-12-22       Impact factor: 3.840

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.